This website uses cookies to ensure you get the best experience on our website. Learn more

COVID-19 Symposium: Epidemiology of SARS-CoV-2 Infection | Dr. Michael Levy

x
  • COVID-19 Symposium: Epidemiology of SARS-CoV-2 Infection | Dr. Michael Levy

    10:12

    Dr. Michael Levy discusses the epidemiology of the SARS-CoV-2 Infection as part of Penn's first Coronavirus Outbreak Symposium.

    #Coronavirus #COVID-19 #PennMedicine

  • x
  • COVID-19 Symposium: Clinical Trials to Treat SARS-CoV-2 Infection | Dr. Ian Frank

    21:46

    #PennMedicine

  • x
  • COVID-19 Pandemic Grand Rounds: Epidemiology, Transmission, Diagnostics and Clinical Course

    55:15

    In this April 9, 2020 grand rounds, Keck Medicine of USC physicians discuss COVID-19's epidemiology, transmission, diagnostics and clinical course.

    AGENDA

    Topic 1: Epidemiology and transmission/infectivity
    Neha Nanda, MD, medical director of infection prevention and antimicrobial stewardship at Keck Medicine of USC and clinical associate professor of medicine

    Topic 2: Diagnostics
    Andrea Kovacs, MD, division head of Maternal, Child and Adolescent Center for Infectious Diseases and professor of pediatrics, pathology and preventive medicine

    Topic 3: Initial clinical presentation, course, risk stratification and home care
    Rishi Mehta, MD, clinical assistant professor of medicine and Anuj Ohri, MD, clinical assistant professor of medicine

    Topic 4: Pathophysiology of severe illness/criteria for ICU admission
    Zea Borok, MD, chief of the division of pulmonary and critical care medicine and professor of medicine; Santhi Kumar, MD, vice chair for quality and safety and assistant professor of clinical medicine; and Peter Marshall, MD, clinical vice chief of critical care and clinical associate professor of medicine

  • COVID-19 Symposium: Discovery Pipeline for Antivirals Against SARS-CoV-2 | Dr. Sara Cherry

    8:48

    #PennMedicine

  • x
  • Dr. Joe Schwarcz: Epidemiology and COVID-19

    4:24

  • Science of COVID-19: Epidemiology of COVID-19: What we know, what we need to know

    1:15:04

    Marc Lipsitch, Harvard T.H. Chan School of Public Health.

    Dr. Lipsitch is a professor of epidemiology in the Department of Epidemiology and the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. He is also the director of the Center for Communicable Disease Dynamics.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE: janelia.org/scienceofcovid19

  • x
  • The Origins of COVID-19 and SARS-CoV-2 | Stanford DoM Grand Rounds | 7 July 2021

    1:1:26

    In this Department of Medicine Grand Rounds, experts discuss the origins of COVID-19.

    Presenter:

    David A. Relman, MD, Thomas C. and Joan M. Merigan Professor in Medicine, and Professor of Microbiology & Immunology, and Senior Fellow at the Freeman Spogli Institute for International Studies at Stanford University

  • July 2020 ACIP Meeting - Epidemiology of COVID-19; work group considerations

    1:18:11

    Epidemiology of COVID-19 in essential workers, including healthcare personnel; COVID-19 vaccine prioritization: work group considerations; Evidence to Recommendations framework and Work Group next steps

    Comments on this video are allowed in accordance with our comment policy:


    This video can also be viewed at

  • COVID-19 | SARS-CoV-2 , Types ,Epidemiology, Morphology and Pathogenesis

    14:40

  • x
  • Dr. Angela Rasmussen: Demystifying COVID-19. The Science of SARS-CoV2 Epidemiology and Transmission

    1:21:10

    Virologist Angela Rasmussen delivers a three-part series of virtual talks, “Demystifying COVID-19: The Science of SARS-CoV-2”. The Dialogues series is cohosted by Janelia and Loudoun County Public Library.

  • SARS–CoV-2 infection and COVID-19: Current epidemiology and prospects for control, George Rutherford

    37:02

    Dr. Rutherford will provide an update on the facts surrounding Covid transmission, impact of new variants discovered in California, optimism surrounding new vaccines and why initial distribution efforts have been slower than hoped.


    George W. Rutherford, M.D., is the Salvatore Pablo Lucia Professor of Epidemiology, Preventive Medicine, Pediatrics and History and Head of the Division of Infectious Disease and Global Epidemiology in the Department of Epidemiology and Biostatistics, University of California, San Francisco. Educated at Stanford University and Duke University School of Medicine, he is board certified in pediatrics and general preventive medicine and public health. His expertise is in the epidemiology and control of communicable diseases of public health significance with a focus on HIV, Ebola virus and Zika virus infection in low- and middle-income countries. Dr. Rutherford serves as an advisor to the Centers for Disease Control and Prevention and the World Health Organization. He has been involved in the public health response to SARS-CoV-2 since the earliest days of the pandemic.

  • Epidemiology of Coronavirus | Special Issue

    6:10

    #Epidemiologyofcoronavirus #epidemiology #publichealth #statistics #managewithcovid #dealwithanxiety #dealwithstress #children #mentalhealth #protectfromcoronavirus #protectothers #coronavirus #covid-19 #WHO #healthpolicy #symptoms #outbreak #coronadisease #virus #WHO #symptoms #protection


    Epidemiology of Coronavirus (COVID-19) | Special Issue

    This video is about the basic and early epidemiology of Coronavirus (COVID-19). Please check links below to stay informed with accurate data from official sources.

    LINKS:

    The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak -

    Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review -

    Coronavirus Disease 2019 (COVID-19) -

    Novel coronavírus WHO Video (2019-nCoV) -

    ONU -

    WHO Coronavirus disease (COVID-19) outbreak
    -

    Global Situation Dashbord -

    BOOKS:

    MERS Coronavirus: Methods and Protocols (Methods in Molecular Biology) -

  • COVID-19 Symposium: Coronavirus History, Replication, and Immune Evasion | Dr. Susan Weiss

    54:13

    Dr. Susan Weiss, Co-Director of the Penn Center for Research on Coronavirus and Other Emerging Pathogens, gives a detailed presentation on the history of coronaviruses, how they replicate, and their ability to evade immune responses in the body.

    Dr. Weiss is a world-renowned leader in coronavirus research at the University of Pennsylvania.

    #Coronavirus #COVID-19 #PennMedicine

  • Epidemiology of COVID-19

    1:4:28

    A scientific explanation of COVID-19 symptoms, modes of transmission and current status of vaccine development, this presentation will be prefaced with the questions, “What is a Virus?”, “Why is this virus so dangerous?”, and “How did COVID-19 become a Pandemic?” This presentation is led by UM-Dearborn expert Raji Janakiraman, PhD. Part three of a six part series.

    Pandemic Perspectives is a free, virtual course. This series of six expert talks will cover a broad array of pandemic-related topics. UM-Dearborn faculty will apply their researched perspectives to help you better understand pandemic sources, consequences, implications and precedents of the Coronavirus/COVID-19 pandemic.

    To learn more, visit

    Note: captions are auto-generated. Please excuse any errors!

  • UCSF Experts on the Epidemiology, Science, & Clinical Manifestations of COVID-19, and UCSF Response

    1:40:51

    In this UCSF Medical Grand Rounds presentation (March 19, 2020), nine UCSF experts describe the epidemiology, virology, clinical manifestations, pathophysiology, and treatments for COVID-19. The session is hosted by UCSF Department of Medicine chair Bob Wachter.

    Program

    Bob Wachter: Introduction
    0:03:00 - Diane Havlir: Epidemiology [imperfect audio, gets better]
    0:15:00 - Jen Babik: Clinical Presentation
    0:26:00 - Michael Matthay: The Lung Disease of COVID-19 (ARDS), Clinical Aspects and Pathophysiology
    0:36:00 - Annie Luetkemeyer: Treatments, Now and On the Horizon
    0:55:00 - Q&A
    1:02:00 - Panel Discussion on the UCSF Response, with 5 more UCSF experts: Matt Aldrich (Critical Care), Sarah Doernberg (ID and Infection Prevention), Chaz Langelier (Virology and Testing), Brad Monash (Hospital Medicine), and Debbie Yokoe (ID and Epidemiology)
    1:39:00 - Bob Wachter: Closing

  • How Can Coronavirus Harm You? | SARS-CoV-2 Pathophysiology

    16:58

    READ MORE BELOW!

    In this video, we will explore how Coronavirus (SARS-CoV-2) can harm individuals by exploring its pathophysiology, immunopathology, and evasion of host immune defenses.

    INSTAGRAM | @thecatalystuniversity
    I’m starting an Instagram page @thecatalystuniversity for additional helpful content and other things I find fun and interesting including but not limited to:
    Helpful Anatomy & Physiology Summary Figures
    Rescores of Famous Movies and TV shows with Epic Music (e.g., Dragon Ball Z)
    Cats & More Cats

    MERCHANDISE
    Be sure to check out custom Catalyst University merchandise!
    LINK |

    PATREON
    LINK |

  • COVID-19 | Coronavirus: Epidemiology, Pathophysiology | APRIL UPDATE

    47:28

    This Video Was Posted April, 2020. As the COVID-19 Pandemic is always evolving, the information presented this is video may no longer reflect current findings and research.

    Official Ninja Nerd Website:
    Ninja Nerds!

    In this lecture Professor Zach Murphy will present on COVID-19- Coronavirus: Epidemiology, Pathophysiology | APRIL UPDATE.

    Join us for our lecture on COVID-19 where we will go into detail on the virology, epidemiology, and pathophysiology/pathology of COVID-19. This is our April update on our previous lecture to keep all of our viewers informed on the new research and publications that have been released on COVID-19. Please be aware— This lecture is up to date as of April 17, 2020. We hope you enjoy this lecture and be sure to support us below!

    Outline:

    00:00 - Intro
    00:15 - Virology Overview
    04:52 - Zoonotic Theories (Homologous Recombination))
    07:57 - SARS COV2 S and L Variants
    10:43 - Epidemiology
    13:36 - Rate of Transmission
    18:25 - Pathophysiology
    23:03 - Infection Methodology
    28:27 - Interferon Interactions
    42:40 - Multi-System Organ Damage
    45:40 - ACE-2 Issues
    46:46 - Wrap up

    Join this channel to get access to perks:


    APPAREL |


    DONATE
    PATREON |
    PAYPAL |

    SOCIAL MEDIA

    FACEBOOK |

    INSTAGRAM |

    TWITTER |
    @NinjaNerdSci

    DISCORD |

    #COVID #ninjanerd #covid_19

  • Epidemiology Grand Rounds | Estimating Who Has Experienced Prior COVID-19 Infection

    1:29:19

    May 8, 2020

    Antibody tests are being used to estimate the fraction of the population who have experienced prior COVID-19 infection. However, without sound sampling techniques, the conclusions we can draw from such studies are limited. In this Grand Rounds, faculty, students and staff from the Department of Epidemiology & Biostatistics discuss recent studies of antibody seroprevalence, why sampling matters and best practices moving forward.

  • COVID-19 Symposium: Introduction to Coronavirus and the Penn Community Response | Dr. Ronald Collman

    54:14

    Dr. Ronald Collman discusses the COVID-19 pandemic, how this coronavirus spread, and how the Penn and Philadelphia communities are handling it. This video also features a Q&A with Dr. Susan Weiss, Co-Director of the Penn Center for Research on Coronavirus and other Emerging Pathogens.

    #Coronavirus #COVID-19 #PennMedicine

  • SARS-CoV-2

    1:27

    Presented By: Mark Denison, MD

    Speaker Biography: Mark Denison M.D. is the Craig-Weaver Professor of Pediatrics, Pathology, Microbiology & Immunology at Vanderbilt University Medical Center in Nashville, TN. Dr. Denison has performed over 25 years of NIH-funded research focused on the replication, pathogenesis, and evolution of coronaviruses, a family of RNA viruses from which SARS-CoV emerged.

    Webinar: SARS-CoV-2 (CoVID-19: Emergence, Biology, and Countermeasures)

    Earn PACE Credits:
    1. Make sure you’re a registered member of LabRoots (
    2. Watch the webinar on YouTube or on the LabRoots Website (
    3. Click Here to get your PACE credits (Expiration date – 04/02/2022):

    LabRoots on Social:
    Facebook:
    Twitter:
    LinkedIn:
    Instagram:
    Pinterest:
    SnapChat: labroots_inc

  • x
  • The COVID 19 pandemic: epidemiology

    42:02

    Introduced by virologist and College Fellow, Professor Will Irving, this RCPath seminar series looks at COVID-19 and its implications for and impact on pathology.

    The fifth in the series discusses the epidemiology of COVID-19 and is presented by Professor Sunetra Gupta, Professor of Theoretical Epidemiology at University of Oxford.

  • COVID-19 in Children Seminar Series: Pediatric Epidemiology and Transmission of COVID-19

    1:27

    Recorded on 11.05.20

    Presented by
    Yvonne Maldonado, MD, FAAP, FPIDS, FIDSA
    Division Chief, Pediatric Infectious Diseases
    Professor, Pediatric Infectious Diseases and Health Research Policy

    View CME information at

  • SARS-CoV-2 and the COVID-19 Pandemic

    24:10

    Warner Greene, MD, PhD brings his expertise in the field of virology to share:
    -Science Behind the Virus
    -Steps You Can Take to Protect Yourself
    -Research at Gladstone on SARS-Cov-2 and the illness it causes, COVID-19
    -Where the Pandemic is Headed

    Stay informed and contribute to Gladstone’s efforts fighting COVID-19 at gladstone.org/donate.

    #COVID19 #Coronavirus

  • Covid-19: Epidemiology Update, and the Tenuous Balance between Speed and Safety in the Pandemic

    1:16:09

    In this UCSF Medical Grand Rounds presentation (June 11, 2020), UCSF experts provide an update on the epidemiology for COVID-19 and the next phase of the pandemic. They also highlight the shift to speed in publications and the FDA approval process – raising the question of whether safety is being compromised. The session is hosted by UCSF Department of Medicine chair Bob Wachter.

    Program
    Bob Wachter: Introduction
    00:05:41 – George Rutherford, Professor, Dept. of Epidemiology & Biostatistics, UCSF; Director of the Prevention and Public Health Group – Update in Epidemiology and the New Phase of the Pandemic
    00:22:53 – Q&A
    00:29:37 – A panel discussion with Dr. Rutherford and the speakers below – The Shift to Speed in Publications and the FDA Approval Process: An Appropriate Response to a Pandemic or Setup for Errors?
    • Rob Califf, Director of Medical Strategy and Policy, Verily and Google Health; former Commissioner of the US Food & Drug Administration; and Founding Director of the Duke Clinical Research Institute (DCRI)
    • Vinay Prasad, Associate Professor, Depts. of Epidemiology & Biostatistics and Medicine, UCSF; and author of Ending Medical Reversal and Malignant: How Bad Policy and Bad Evidence Harm People with Cancer
    • Rita Redberg, Professor of Medicine, Division of Cardiology, UCSF; and Editor, JAMA Internal Medicine
    01:15:43 – Bob Wachter: Closing

    See previous Covid-19 Medical Grand Rounds:
    • June 4: The Covid-19 Pandemic in the Context of the Healthcare System, Economy, Race, Politics, Ethics, and History

    • May 28: Update on Covid-19: Testing, ICU Practices and Outcomes at ZSFG, and the Experience of Elders in the Covid-19 Pandemic

    • May 21: Update on Covid-19: Epidemiology, Treatments and Vaccines, Thromboembolic Complications, and the Multisystem Inflammatory Syndrome Affecting Children

    • May 14: Covid-19 Update: The ICU Experience in New York, the UCSF Mission and Bolinas Community Studies, and the Uses and Limitations of Antibody Testing


    See all UCSF Covid-19 grand rounds here:

  • How Yale Genomic Epidemiologists Use Mutations to Track the COVID-19 Pandemic

    3:42

    Learn more about the Yale School of Medicine's response to COVID-19, visit:

    Dr. Nathan Grubaugh is an assistant professor of epidemiology at the Yale School of Public Health and uses genomic epidemiology to study viral outbreaks. His background has led him to studying the mutations in COVID-19 to track the spread of the virus.

    Faculty across Yale, including at the School of Medicine, School of Nursing, School of Public Health, School of Engineering & Applied Science and Faculty of Arts and Sciences are actively engaged in research, innovation, and clinical efforts to combat COVID-19.

    Attribution:




  • COVID-19 Symposium: Q&A Session | Dr. Norbert Pardi and Henry Li

    6:45

    #PennMedicine

  • Covid-19 Update: Epidemiology, Virology, Drugs & Vaccines, and UCSF’s Experience in Navajo Nation

    1:39:18

    In this UCSF Medical Grand Rounds presentation (May 7, 2020), UCSF experts provide an update on the epidemiology and virology for COVID-19, prospects for drugs and vaccines, and the role of biopharmaceutical companies. We also hear a brief report from a UCSF physician who is part of a volunteer group of 21 faculty and nurses working in the Navajo Nation. The session is hosted by UCSF Department of Medicine chair Bob Wachter.

    Program
    Bob Wachter: Introduction
    00:02:16 – Sriram Shamasunder, Associate Professor of Medicine, UCSF Division of Hospital Medicine; Director of the HEAL Initiative – Report from the Navajo Nation
    00:13:22 – George Rutherford, Professor, Dept. of Epidemiology & Biostatistics; Director of the Prevention and Public Health Group – Epidemiology and the Next Stage
    00:25:20 – Q&A
    00:32:32 – Joel Ernst, Professor of Medicine and Chief of UCSF Division of Experimental Medicine – Viral Immunity and Vaccines
    00:45:45 –Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology and Professor, Dept. of Medicine – Virology of SARS-CoV-2
    00:58:55 – Nevan Krogan, Professor, Dept. of Cellular and Molecular Pharmacology; Director of Quantitative Biosciences Institute – SARS-CoV-2 and Drug Discovery
    01:13:30 – Panel Discussion including Joel Ernst, Melanie Ott, Nevan Krogan and:
    • Donald Ganem, Professor Emeritus of Medicine, Division of Infectious Diseases; Head of Infectious Disease Research at Novartis, 2011-18 – SARS-CoV-2 and the Role of Biopharmaceutical Companies
    01:38:23 – Bob Wachter: Closing

    See previous Covid-19 Medical Grand Rounds:
    • April 30: Update on Covid-19: Clinical & Neurological Manifestations, Contact Tracing, and UCSF’s Experience in NYC

    • April 23: Update on Covid-19: The Next Stage of the Pandemic, Virology & Diagnostics
    • April 16: Update on Covid-19: Epidemiology, Treatments, and Health Disparities

    • April 9: Update on Covid-19, at UCSF and Around the Country

    • April 2: Epidemiology, Science, Clinical Aspects, and Therapy for Covid-19, Part 2

    • March 26: Impact on Covid-19 on Medical Education

    • March 26: UCSF Researchers Tackling Covid-19

    • March 19: Epidemiology, Science, Clinical Aspects, and Therapy for Covid-19, Part 1

  • Michael Mina: “Epidemiology”

    55:50

    The eighth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Michael Mina of the Harvard T. H. Chan School of Public Health gave a talk titled “Epidemiology.” For more information on the class, visit

    Date: 10/27/2020

    Help us make more classes like this free to the public:

    --

    Watch more videos from MIT Bio:

    The department is home to approximately 180 undergraduates, 200 graduate students, 200 postdoctoral researchers, and more than 60 world-renowned faculty, including:
    - 3 Nobel laureates
    - 30 members of the National Academy of Sciences
    - 15 Howard Hughes Medical Institute (HHMI) investigators
    - 4 recipients of the National Medal of Science

    We promote a highly collaborative environment that allows for a free exchange of ideas across research areas and academic disciplines. The result is a rigorous, creative, dynamic culture in which scientists and students tackle the important problems and questions in biology and related fields. Our location — at the heart of one of the world’s most important biotech/pharma hubs — creates exciting opportunities for research, employment, and the commercialization of new discoveries.

    For information on captioning and accessibility at MIT, visit

  • SARS-CoV-2 Introduction - Creative Biolabs

    9:57

    Creative Biolabs has extensive experience in coronavirus research. Provide comprehensive high-quality coronavirus (SARS-CoV-2, SARS-CoV, MERS-CoV, etc.) related services and products.
    This video provides a brief introduction to SARS-CoV-2. If you need more knowledge, products and services related to SARS-CoV-2, please follow us.

  • CRRG Webinar: Epidemiology of COVID-19: Implications for Control

    1:29:04

    Speaker: Marc Lipsitch, Harvard University
    Moderator: Thomas Bortfeld, Harvard University

    Topics covered during this webinar:
    • Key features of the epidemiology of the COVID-19 pandemic with emphasis on the complexity of the data-generating mechanisms, and the challenges they pose for control
    • Delayed and incomplete reporting, local heterogeneity, and uncertain effectiveness of control measures
    • Approaches to address these challenges
    • Nowcasting and detailed sensitivity analyses in models
    • Big open questions in the epidemiology of COVID-19

  • Understanding the Spread of COVID-19

    14:04

    Dr. Josh Sharfstein interviews infectious disease epidemiologist Dr. Justin Lessler on the features of viruses that lead to worldwide contagion, how COVID-19 compares with the flu in terms of speed, and where the evidence now points for this novel coronavirus.

    Dr. Justin Lessler is an Associate Professor in Epidemiology. Dr. Josh Sharfstein is the Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health.

  • Updates on COVID-19 Epidemiology and Vaccination | Yonatan H. Grad, MD, PhD

    24:41

    Lecture: Updates on COVID-19 Epidemiology and Vaccination
    Speaker: Yonatan H. Grad, MD, PhD
    Harvard T.H. Chan School of Public Health, United States
    Presented at: COVID-19 Vaccine Development & Implementation Workshop 2021 | June Edition

    Learn more about the COVID-19 Vaccine Development & Implementation Workshop via

    The COVID-19 Vaccine Development & Implementation Workshop aims to increase knowledge and facilitate discussion on the many aspects of vaccine development and rollout on a background of a firm understanding of pathogenesis and natural infection. Our goal is to address the many scientific, social, and policy challenges in the totality of delivering an effective COVID-19 vaccine.

    For more medical education programs, as well as the latest scientific information, visit

  • COVID-19 Symposium: Coronavirus-host Cell Interactions | Henry Li

    11:26

    #PennMedicine

  • Prof. Dr. Abbas Ali Mansour / DM & COVID-19; Epidemiology, Pathophysiology and Risks

    20:34

  • The Epidemiology of COVID 19: Where Do We Go From Here? Final

    54:49

    Presented on Monday, May 18, 2020 by Dr. Matthew McQueen

    The Coronavirus disease (COVID-19) pandemic has profoundly impacted our personal and professional lives. We take a moment to step back to explore where we are currently at with this virus and what scenarios may lie ahead.

    About the Presenter: Dr. Matthew McQueen (ScD) is an Associate Professor of Integrative Physiology and Director for the Public Health Certificate Program on the CU Boulder campus. Dr. McQueen is an epidemiologist by training and is engaged in a highly interdisciplinary research program. He teaches Introduction to Epidemiology for the public health certificate program as well as introductory and advanced biostatistics for the Department of Integrative Physiology.

    Learn more about the Leeds Alumni Webinar Series at

  • Covid-19 Update: Epidemiology, Treatments and Vaccines, Clotting, & the New Pediatric Syndrome

    1:43:38

    In this UCSF Medical Grand Rounds presentation (May 21, 2020), UCSF experts provide an update on the epidemiology for COVID-19, prospects for treatments and vaccines, and thromboembolic complications in Covid-19. They also highlight emerging evidence regarding the multisystem inflammatory syndrome and how the virus is affecting children. The session is hosted by UCSF Department of Medicine chair Bob Wachter.

    Program
    Bob Wachter: Introduction
    00:01:56 – George Rutherford, Professor, Dept. of Epidemiology & Biostatistics; Director of the Prevention and Public Health Group – Updates in Epidemiology and the Role of Masks
    00:24:53 – Annie Luetkemeyer, Professor of Medicine, Division of HIV, ID and Global Medicine, ZSFG – Updates in Therapies for Covid-19
    00:46:41 – Joel Ernst, Professor of Medicine and Chief of Division of Experimental Medicine, ZSFG – The Moderna Vaccine News: What Does it Mean?
    01:03:03 – Andrew Leavitt, Professor, Depts. of Laboratory Medicine and Medicine; Director of UCSF's program for Noncancerous Blood Disorders – Thromboembolic Complications in Covid-19
    01:23:35 – Susan Kim, Associate Professor, Division of Pediatric Rheumatology – Multisystem Inflammatory Syndrome in Children
    01:43:02 – Bob Wachter: Closing

    See previous Covid-19 Medical Grand Rounds:
    • May 14: Covid-19 Update: The ICU Experience in New York, the UCSF Mission and Bolinas Community Studies, and the Uses and Limitations of Antibody Testing

    • May 7: Update on Covid-19: Epidemiology, Virology, Prospects for Drugs and Vaccines, and UCSF’s Experience in the Navajo Nation

    • April 30: Update on Covid-19: Clinical & Neurological Manifestations, Contact Tracing, and UCSF’s Experience in NYC

    • April 23: Update on Covid-19: The Next Stage of the Pandemic, Virology & Diagnostics
    See all UCSF Covid-19 grand rounds here:

  • The importance of targeted NGS for SARS-CoV-2 epidemiology and transmission studies

    1:14

    Learn how targeted NGS can complement qPCR to enable critical information for emerging SARS-CoV-2 epidemiology applications. See how targeted NGS can complement qPCR detection to enable emerging SARS-CoV-2 epidemiology applications like contact tracking/tracing, wastewater-based epidemiology, retrospective studies, zoonotic analysis and more. Learn more and request a virtual demo at

  • RSPH COVID-19 Epidemiology Fellowship

    3:36

    The Emory COVID-19 Response Collaborative (ECRC) is a new initiative in the Department of Epidemiology to support Georgia’s public health partners during the COVID-19 crisis and into the future. This 2-year Fellowship program will support new epidemiologists and increase epidemiologic capacity throughout the state. For more information and to apply, please visit emorycovidcollaborative.org.

  • The Epidemiology of COVID 19: One Year Later

    1:1:41

    Presented on Friday, February 12, 2021 by Dr. Matthew McQueen

    Description: On February 11, 2020 the World Health Organization announced “COVID-19” as the official name associated with the 2019 novel coronavirus outbreak that first emerged in Wuhan, China. Since that announcement, we’ve learned a tremendous amount about the virus, how it spreads and who is most vulnerable. During this webinar, we will look back on this tumultuous and tragic year of lessons learned while also peering into the immediate future of what may come.

    Presenter Bio: Dr. Matthew McQueen (ScD) is an Epidemiologist and Professor of Integrative Physiology and Director for the Public Health Certificate Program on the CU Boulder campus. Dr. McQueen is engaged in a highly interdisciplinary research program and is the Director of Epidemiology for the CU Boulder Pandemic Response Office. He teaches Introduction to Epidemiology for the public health certificate program as well as introductory and advanced biostatistics for the Department of Integrative Physiology.

  • Combating COVID-19 with Epidemiology

    3:01

    Pasadena Public Health Epidemiologist Dr. Matt Feaster shares what epidemiology is and how epidemiologists investigate COVID-19 cases. Dr. Feaster also encourages you to get tested if you think you may have COVID-19.

  • COVID-19: Intro & the Basics | Scientific Research Explained in Simple Terms, Part 1

    7:23

    COVID-19: Intro & the Basics introduces basic epidemiology concepts such as attack and fatality rates, prevalence, and reproductive numbers – plus the difference between SARS-CoV-2 and COVID-19. This lay the groundwork for our future videos, exploring the latest scientific evidence about COVID. We also cover what this video series is and isn't.

    #covid-19 #covid #pandemic #epidemiology

    CONTENTS
    =============================
    0:00 Why am I making this video?
    0:46 Why now?
    1:27 What this video isn't
    1:57 Why trust me?
    2:54 Data
    3:37 Epidemiology defined
    4:03 Attack rates
    4:24 Prevalence
    4:45 Case fatality rates
    4:57 Infection fatality rates
    5:17 Reproductive numbers
    6:39 Nomenclature - Coronavirus vs COVID

    REFERENCES
    =============================
    Murk W, Gierada M, Fralick M et al. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study. CMAJ. 2021;193:E10-E18. doi.org/10.1503/cmaj.201686

    Ng TC et al. Spatially Adjusted Time-varying Reproductive Numbers: Understanding the Geographical Expansion of Urban Dengue Outbreaks. Sci Rep. 2019;9:19172. doi.org/10.1038/s41598-019-55574-0

    Principles of Epidemiology in Public Health Practice, Third Edition: An Introduction to Applied Epidemiology and Biostatistics:

    Subramanian R, He Q, Pascual M. Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity. Proc Natl Acad Sci USA. 2021;118. doi.org/10.1073/pnas.2019716118

  • OmicsLogic Research Fellowship Project: SARS-COV-2 Infection gene expression data analysis study

    17:08

    Analysis of transcriptomics profile of SARS_COV-2 infected cell lines to understand the mechanisms of action of repurposed drugs for COVID-19 treatment, a project by Dr. Emeka Patrick Chukwuka (Saudi Arabia, Nigeria) and Dr. Anita Ghansah (Ghana). A research study developed as a part of the Omics Logic research fellowship program designed to help researchers apply bioinformatics analysis tools to public domain datasets. Learn more:

  • SARS-CoV-2 Epidemiology Research with Ion Torrent Targeted Next-Generation Sequencing

    3:35

    Targeted NGS enables complete SARS-CoV-2 genome sequencing for contact tracking and tracing, wastewater based epidemiology, retrospective analysis and more

  • 2021 RNDS | COVID-19 and rare neuroimmune disorders

    41:35

    Drs. Michael Levy, Carlos Pardo, and Benjamin Greenberg discussed what is currently known about COVID-19 and rare neuroimmune disorders, including risk factors for people with a rare neuroimmune disorder, whether COVID-19 infection can cause a relapse or new inflammatory event, and data on long-haul symptoms following COVID-19 infection. The experts also talked about the COVID-19 vaccines and considerations for people with rare neuroimmune disorders who are making decisions about their care.

  • COVID 19 Epidemiology

    6:49

    The spread of the SARS-CoV-2 virus has been dramatic causing disease worldwide. How did this happen? How is the virus spread to others? Why has the spread been so rapid? Why are many countries failing to contain the virus? The answers are in this video.

  • Early Epidemiology and why SARS-COV2 was not made in a Lab

    11:45

    #mindbraintalks #COVID19epidemiology #SARS-COV2notmadeinalab

    Early Epidemiology and why SARS-COV2 was not made in a Lab

    In this video, you will find the early epidemiology of SARS-COV2. Also, you will find a scientific explanation to support the notion of why SARS-COV 2 was not made not in the lab. Please check links below to stay informed with accurate data from official sources.

    LINKS:

    The proximal origin of SARS-CoV-2 -

    The coronavirus did not escape from a lab. Here's how we know -

    Theory that Coronavirus Escaped from a Lab Lacks Evidence -

    Coronavirus Disease 2019 (COVID-19) -

    Novel coronavírus WHO Video (2019-nCoV) -

    ONU -

    WHO Coronavirus disease (COVID-19) outbreak
    -

    Global Situation Dashbord -

    BOOKS:

    MERS Coronavirus: Methods and Protocols (Methods in Molecular Biology) -

  • Latest Insights into the Epidemiology of COVID-19 in Nephrology from ERACODA

    57:19

    By
    Prof. Ron Gansevoort
    Dr. Samira Bell
    Prof. Luuk Hilbrands
    Prof. Kitty J. Jager
    Prof. Alberto Ortiz



  • Will Be Other Covid Vaccines, Says Epidemiology Professor

    4:47

    Nov.10 -- Ben Cowling, professor of infectious disease epidemiology at Hong Kong University, discusses the potential new Pfizer vaccine, the production of other vaccines and the increasing infection rate of Covid-19. He speaks on “Bloomberg Market: China Open.”

  • Highlights: UW, Johns Hopkins symposium COVID-19 vaccine research

    3:53

    Watch the full symposium replay, which was held virtually on Oct. 6, 2020, here:

  • The Epidemiology and Economics of Coronavirus

    3:41:22

    The COVID-19 global health pandemic is rapidly changing the ways we live and work. In the age of sustainable development and at a time when the world is working towards achieving the SDGs, this disease is complicating SDG implementation efforts as well as posing a real risk to achieving targets on communicable disease, education, life expectancy, and decent work. This virtual conference event will seek to examine the implications of COVID-19 for public health and the SDGs, as well as make recommendations on science-based responses.


    ---
    Full summary of the webinar is available at:

Shares

x

Check Also

Menu